Bonebridge

MED-EL USA Launches SAMBA 2 Audio Processor for the BONEBRIDGE Bone Conduction System

Retrieved on: 
Wednesday, January 6, 2021

MED-EL USA, a leader in implantable hearing solutions, today announced the launch of the SAMBA 2, a next-generation audio processor for the BONEBRIDGE Bone Conduction System, which includes the recently launched BCI 602.

Key Points: 
  • MED-EL USA, a leader in implantable hearing solutions, today announced the launch of the SAMBA 2, a next-generation audio processor for the BONEBRIDGE Bone Conduction System, which includes the recently launched BCI 602.
  • View the full release here: https://www.businesswire.com/news/home/20210106005133/en/
    MED-EL USA launches SAMBA 2 next-generation audio processor for the BONEBRIDGE Bone Conduction System.
  • In 2018, after successful use internationally, MED-EL USA launched the countrys first active transcutaneous bone conduction system, BONEBRIDGE, marking the beginning of a new era in bone conduction stimulation.
  • The groundbreaking BONEBRIDGE Bone Conduction System was comprised of an internal implant, BCI 601, and the externally worn SAMBA Audio Processor.